Home

bemenet bizonyság Nyisd ki ghit fund for infectious diseases research kedvéért tisztító Krumpli

GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND

EISAI CO-ESTABLISHES THE GLOBAL HEALTH INNOVATIVE TECHNOLOGY FUND
EISAI CO-ESTABLISHES THE GLOBAL HEALTH INNOVATIVE TECHNOLOGY FUND

Global Infectious Diseases Institute
Global Infectious Diseases Institute

Japanese GHIT Fund to include diagnostics and drugs for leishmaniasis
Japanese GHIT Fund to include diagnostics and drugs for leishmaniasis

A new Korean Research Investment for Global Health Technology (RIGHT) Fund  to advance innovative neglected-disease technologies | PLOS Neglected  Tropical Diseases
A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies | PLOS Neglected Tropical Diseases

GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND

Research-based pharmaceutical industry 360-degree efforts to fight  Neglected Tropical Diseases (NTDs) 2013 - IFPMA
Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA

Estimating the cost of vaccine development against epidemic infectious  diseases: a cost minimisation study - The Lancet Global Health
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study - The Lancet Global Health

The Global Health Innovative Technology Fund provides grant to Mitsubishi  Tanabe Pharma and DNDi for Chagas disease and leishman
The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishman

GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND

Malaria Research—What Next? | Science
Malaria Research—What Next? | Science

Investment Opportunities | Global Health Innovative Technology Fund
Investment Opportunities | Global Health Innovative Technology Fund

From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant  Malaria, $10.7 Million in New Investments from GHIT
From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant Malaria, $10.7 Million in New Investments from GHIT

GLOBAL HEALTH TECHNOLOGY DISCOVERY AND DEVELOPMENT GHIT Fund Request for  Proposals
GLOBAL HEALTH TECHNOLOGY DISCOVERY AND DEVELOPMENT GHIT Fund Request for Proposals

GHIT Fund Brochure — BI BOOP
GHIT Fund Brochure — BI BOOP

GHIT Fund Archives - Asian Scientist Magazine
GHIT Fund Archives - Asian Scientist Magazine

GHIT Fund Archives - Asian Scientist Magazine
GHIT Fund Archives - Asian Scientist Magazine

GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product  Development of Neglected Tropical Diseases
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases

Japanese GHIT Fund names new sponsors and funders
Japanese GHIT Fund names new sponsors and funders

Neglected tropical diseases - Wikipedia
Neglected tropical diseases - Wikipedia

A New Partner for Global Health Innovative Technology (GHIT) Fund
A New Partner for Global Health Innovative Technology (GHIT) Fund

Division of Infectious Diseases and Epidemiology - Penn State College of  Medicine
Division of Infectious Diseases and Epidemiology - Penn State College of Medicine

What Can a Pharmaceutical Company Do to Save People from Infectious Diseases?  - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories -  Daiichi Sankyo
What Can a Pharmaceutical Company Do to Save People from Infectious Diseases? - An interview with Osamu Kunii, CEO of the GHIT Fund - Our Stories - Daiichi Sankyo